Hims & Hers Health Inc. Class A Common Stock (HIMS)
Stock · NYSE · Health Care
$28.06as of 10/16/2026
Price chart
Active signals
HIMS Signal Track Record
How signals performed across all stocks →What HIMS's price did in the 20 trading sessions after each past signal, compared with any 20-session window over the same period.
| Signal | Times | Median 20-session return | Higher after 20 sessions | Last signal |
|---|---|---|---|---|
| Volume Spike | 32 | +1.0% | 50% | September 22, 2026 |
| Bollinger Band Breakout | 27 | -0.6% | 48% | October 9, 2026 |
| Bollinger Band Breakdown | 17 | -2.5% | 47% | July 24, 2026 |
| 200-Day Moving Average TouchActive now | 11 | +2.5% | 55% | September 16, 2026 |
| Any 20-session window (baseline) | +1.0% | 51% |
Computed by MarketWall from daily closing prices since May 18, 2022. Returns are close-to-close and don't include dividends. Past results describe what happened before; they are not a forecast and not investment advice.
About HIMS
Hims & Hers Health, Inc. operates as a consumer-first health and wellness platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, Canada, Germany, the Republic of Ireland, France, Spain, Australia, and internationally. The company offers a range of curated prescription and non-prescription health and wellness products and services available to purchase on its we…
- Sector
- Health Care
- Industry
- Medical/Nursing Services
- Employees
- 2,442
- Website
- www.forhims.com/
Fundamentals
- 1-day range
- $26.33$29.65
- Market cap
- $6.87B
- P/E (trailing)
- —
- P/E (forward)
- 39.85
- EPS (trailing)
- $-0.63
- Dividend yield
- —
- Beta
- 2.52
- Avg. volume
- 12.03M
How Hims & Hers Health Inc. Class A Common Stock Makes Money
Where the revenue actually goes — FY2025 annual results
Source: 10-K filed Feb 23, 2026 · via SEC EDGAR / Finnhub
Forecasts
13 analyst ratings
Hims & Hers Health Inc. Class A Common Stock Competitors
Chosen by industry and closest market cap.
- HIMSHims & Hers Health Inc. Class A Common Stock$28.07▼ 4.46%Market cap $6.87BP/E —$13.74$65.3
- LFSTLifeStance Health Group Inc. Common Stock$11.74▼ 5.09%Market cap $4.13BP/E 93.42$4.77$13.56
- OPCHOption Care Health Inc. Common Stock$31.2▼ 0.06%Market cap $3.54BP/E 22.23$18.01$36.8
- PRVAPrivia Health Group Inc. Common Stock$22.52▼ 0.44%Market cap $2.77BP/E 102.74$18.92$28.82
- ADUSAddus HomeCare Corporation Common Stock$115.98▼ 0.44%Market cap $2.22BP/E 20.70$87.95$124.44
- WGSGeneDx Holdings Corp. Class A Common Stock$63.61▼ 9.41%Market cap $2.08BP/E —$32.21$170.87
- AVAHAveanna Healthcare Holdings Inc. Common Stock$12.34▼ 2.37%Market cap $2.03BP/E 10.04$5.93$14.71
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| HIMS Hims & Hers Health Inc. Class A Common Stock | $6.87B | — | $28.07 | ▼ 4.46% | $13.74$65.3 |
| LFST LifeStance Health Group Inc. Common Stock | $4.13B | 93.42 | $11.74 | ▼ 5.09% | $4.77$13.56 |
| OPCH Option Care Health Inc. Common Stock | $3.54B | 22.23 | $31.2 | ▼ 0.06% | $18.01$36.8 |
| PRVA Privia Health Group Inc. Common Stock | $2.77B | 102.74 | $22.52 | ▼ 0.44% | $18.92$28.82 |
| ADUS Addus HomeCare Corporation Common Stock | $2.22B | 20.70 | $115.98 | ▼ 0.44% | $87.95$124.44 |
| WGS GeneDx Holdings Corp. Class A Common Stock | $2.08B | — | $63.61 | ▼ 9.41% | $32.21$170.87 |
| AVAH Aveanna Healthcare Holdings Inc. Common Stock | $2.03B | 10.04 | $12.34 | ▼ 2.37% | $5.93$14.71 |
P/E shows — for peers not currently carrying a live signal of their own.
Latest news
- 1 Healthcare Stock Worth Your Attention and 2 We Turn DownYahoo · 10/9/2026
- Why Hims & Hers Health, Inc. (HIMS) Dipped More Than Broader Market TodayYahoo · 10/8/2026
- Reasons to Retain Hims & Hers Stock in Your Portfolio for NowYahoo · 10/8/2026
- Hims & Hers Names Jon Franklin as Chief Accounting OfficerYahoo · 10/7/2026
- Cedar Grove Capital Q3 2026 Portfolio UpdateSeekingAlpha · 10/7/2026
- Hims & Hers Health (HIMS) Investment Thesis: Capturing Market Share in the Cash-Pay SpaceYahoo · 10/7/2026
- Tax Gain Harvesting: Tax Alpha With Raul ShahSeekingAlpha · 10/7/2026
- 3 Small-Cap Stocks on Our WatchlistYahoo · 10/7/2026
- 4 Health Care Stocks With Whale Alerts In Today’s Sessionbenzinga · 10/5/2026
Insider Activity
Insider Actions →- Oluyemi Okupe · October 1, 2026 · Sale2.0K @ $29.7
- Soleil Boughton · September 30, 2026 · Sale3.5K @ $29.17
- Oluyemi Okupe · September 22, 2026 · Option Exercise14.0K @ $5.01
- Oluyemi Okupe · September 22, 2026 · Sale29.3K @ $29.95
- Oluyemi Okupe · September 17, 2026 · Sale12.3K @ $28.82
- Soleil Boughton · September 16, 2026 · Sale6.2K @ $27.86
- Mohamed Elshenawy · September 15, 2026 · Sale8.0K @ $28.39
- Michael Chi · September 15, 2026 · Sale14.0K @ $28.39
- Soleil Boughton · September 2, 2026 · Sale3.5K @ $28.33
- Andrew Dudum · August 27, 2026 · J977.6K
- Andrew Dudum · August 25, 2026 · Gift463.3K
- Oluyemi Okupe · August 19, 2026 · Option Exercise4.9K @ $5.01
- Oluyemi Okupe · August 19, 2026 · Sale4.9K @ $29.99
- Soleil Boughton · August 19, 2026 · Sale25.1K @ $27.55
- Deborah M. Autor · August 18, 2026 · Sale16.8K @ $27.85
Institutional Ownership
March 31, 2026
- Total shares held
- 196.38M
- Total value held
- $4.01B
- Institutional holders
- 433
- Unknown26.34M
- Unknown25.05M
- Unknown13.38M
- Unknown11.79M
- Unknown9.34M
- Unknown8.89M
- Unknown7.46M
- Unknown7.42M
- Unknown5.20M
- Unknown4.51M
See the full, filterable feed with live charts on the MarketWall dashboard.
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 7, 2026
Hims & Hers Appoints Regional Medical Officers for Global Growth
Hims & Hers Health has appointed regional chief medical officers to support its global expansion strategy. This move is relevant as the company continues to capture market share in the cash-pay healthcare space. The stock is currently trading near its support level, with analysts maintaining a wide range of price targets.
Hims & Hers Appoints Regional Medical Officers for Global Growth. Hims & Hers Health has appointed regional chief medical officers to support its global expansion strategy. This move is relevant as the company continues to capture market share in the cash-pay healthcare space. The stock is currently trading near its support level, with analysts maintaining a wide range of price targets.